Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Foster

Showing results (1261-1270 of 1,276) with videos related to

Pageof 128
Sort By:
Ageing Research Reviews|October 15, 2015
Successful aging: Advancing the science of physical independence in older adultsStephen D Anton, Adam J Woods, Tetso Ashizawa, et al.
Nature Medicine|October 27, 2020
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master TrialAmy Burd, Ross L Levine, Amy S Ruppert, et al.
Nature Medicine|January 6, 2025
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trialAndrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, et al.
The New England Journal of Medicine|September 6, 2023
Atezolizumab for Advanced Alveolar Soft Part SarcomaAlice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, et al.
Nature Reviews. Endocrinology|January 30, 2018
Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statementFrédéric Brioude, Jennifer M Kalish, Alessandro Mussa, et al.
Blood Advances|October 23, 2023
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AMLSheng F Cai, Ying Huang, Jennie R Lance, et al.
Cancer|April 20, 2023
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master TrialVu H Duong, Amy S Ruppert, Alice S Mims, et al.
Blood|September 15, 2020
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemiaGeoffrey L Uy, Ibrahim Aldoss, Matthew C Foster, et al.
Journal of Sleep Research|April 29, 2021
ENIGMA-Sleep: Challenges, opportunities, and the road mapMasoud Tahmasian, André Aleman, Ole A Andreassen, et al.
Nature|March 10, 2006
A photometric redshift of z = 6.39 +/- 0.12 for GRB 050904J B Haislip, M C Nysewander, D E Reichart, et al.
Pageof 128

Showing results (1261-1270 of 1,276) with videos related to

Sort By:
Pageof 128
Ageing Research Reviews|October 15, 2015
Successful aging: Advancing the science of physical independence in older adultsStephen D Anton, Adam J Woods, Tetso Ashizawa, et al.
Nature Medicine|October 27, 2020
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master TrialAmy Burd, Ross L Levine, Amy S Ruppert, et al.
Nature Medicine|January 6, 2025
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trialAndrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, et al.
The New England Journal of Medicine|September 6, 2023
Atezolizumab for Advanced Alveolar Soft Part SarcomaAlice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, et al.
Nature Reviews. Endocrinology|January 30, 2018
Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statementFrédéric Brioude, Jennifer M Kalish, Alessandro Mussa, et al.
Blood Advances|October 23, 2023
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AMLSheng F Cai, Ying Huang, Jennie R Lance, et al.
Cancer|April 20, 2023
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master TrialVu H Duong, Amy S Ruppert, Alice S Mims, et al.
Blood|September 15, 2020
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemiaGeoffrey L Uy, Ibrahim Aldoss, Matthew C Foster, et al.
Journal of Sleep Research|April 29, 2021
ENIGMA-Sleep: Challenges, opportunities, and the road mapMasoud Tahmasian, André Aleman, Ole A Andreassen, et al.
Nature|March 10, 2006
A photometric redshift of z = 6.39 +/- 0.12 for GRB 050904J B Haislip, M C Nysewander, D E Reichart, et al.
Pageof 128